Updated Population Pharmacokinetic Model of Cabozantinib Integrating Various Cancer Types Including Hepatocellular Carcinoma

por Nguyen, Linh, Chapel, Sunny, Tran, Benjamin Duy, Lacy, Steven
Publicado 2019

Cabozantinib exposure–response analysis for the phase 3 CheckMate 9ER trial of nivolumab plus cabozantinib versus sunitinib in first-line advanced renal cell carcinoma

por Tran, Benjamin Duy, Li, Jing, Ly, Neang, Faggioni, Raffaella, Roskos, Lorin
Publicado 2023